Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Williams

Showing results (471-480 of 517) with videos related to

Pageof 52
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 1, 2025
TGx-DDI (toxicogenomic DNA damage-inducing) biomarker validation: multi-site ring trial supporting regulatory useXiaotong Wang, Christine E Crute, Ashley Allemang, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|July 25, 2023
Error-corrected duplex sequencing enables direct detection and quantification of mutations in human TK6 cells with strong inter-laboratory consistencyEunnara Cho, Carol D Swartz, Andrew Williams, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 27, 2022
A Transformative Vision for an Omics-Based Regulatory Chemical Testing ParadigmKamin J Johnson, Scott S Auerbach, Tina Stevens, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 19, 2018
Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for AtezolizumabBharathi Vennapusa, Brian Baker, Marcin Kowanetz, et al.
Environmental and Molecular Mutagenesis|December 16, 2014
Transcriptional profiling identifies physicochemical properties of nanomaterials that are determinants of the in vivo pulmonary responseSabina Halappanavar, Anne Thoustrup Saber, Nathalie Decan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: a randomized, phase III trialAlfredo Carrato, Anna Swieboda-Sadlej, Marzanna Staszewska-Skurczynska, et al.
Alimentary Pharmacology & Therapeutics|June 20, 2022
A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary IBD centreSusanna Meade, Kamal V Patel, Raphael P Luber, et al.
Drug and Alcohol Dependence|January 11, 2021
The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care systemDerek D Satre, Tory Levine-Hall, Stacy A Sterling, et al.
Journal of Clinical Pharmacology|June 6, 2008
PhRMA white paper on ADME pharmacogenomicsJ Andrew Williams, Tommy Andersson, Tommy B Andersson, et al.
Toxicology and Applied Pharmacology|June 18, 2018
Corrigendum to "MWCNTs of different physicochemical properties cause similar inflammatory responses, but differences in transcriptional and histological markers of fibrosis in mouse lungs" [Toxicol. Appl. Pharmacol., 284 (2015) 16-32]Sarah S Poulsen, Anne T Saber, Andrew Williams, et al.
Pageof 52

Showing results (471-480 of 517) with videos related to

Sort By:
Pageof 52
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 1, 2025
TGx-DDI (toxicogenomic DNA damage-inducing) biomarker validation: multi-site ring trial supporting regulatory useXiaotong Wang, Christine E Crute, Ashley Allemang, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|July 25, 2023
Error-corrected duplex sequencing enables direct detection and quantification of mutations in human TK6 cells with strong inter-laboratory consistencyEunnara Cho, Carol D Swartz, Andrew Williams, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 27, 2022
A Transformative Vision for an Omics-Based Regulatory Chemical Testing ParadigmKamin J Johnson, Scott S Auerbach, Tina Stevens, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 19, 2018
Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for AtezolizumabBharathi Vennapusa, Brian Baker, Marcin Kowanetz, et al.
Environmental and Molecular Mutagenesis|December 16, 2014
Transcriptional profiling identifies physicochemical properties of nanomaterials that are determinants of the in vivo pulmonary responseSabina Halappanavar, Anne Thoustrup Saber, Nathalie Decan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: a randomized, phase III trialAlfredo Carrato, Anna Swieboda-Sadlej, Marzanna Staszewska-Skurczynska, et al.
Alimentary Pharmacology & Therapeutics|June 20, 2022
A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary IBD centreSusanna Meade, Kamal V Patel, Raphael P Luber, et al.
Drug and Alcohol Dependence|January 11, 2021
The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care systemDerek D Satre, Tory Levine-Hall, Stacy A Sterling, et al.
Journal of Clinical Pharmacology|June 6, 2008
PhRMA white paper on ADME pharmacogenomicsJ Andrew Williams, Tommy Andersson, Tommy B Andersson, et al.
Toxicology and Applied Pharmacology|June 18, 2018
Corrigendum to "MWCNTs of different physicochemical properties cause similar inflammatory responses, but differences in transcriptional and histological markers of fibrosis in mouse lungs" [Toxicol. Appl. Pharmacol., 284 (2015) 16-32]Sarah S Poulsen, Anne T Saber, Andrew Williams, et al.
Pageof 52